Skip to main content
GLOBAL REGULATORY AGENCIES

Generate Submissions for 27 Global Agencies

DossiAIr supports agency-specific formatting, templates, and regulatory requirements for 27 global authorities including FDA, EMA, PMDA, NMPA, Health Canada, TGA, SAHPRA, MHRA, CDSCO, COFEPRIS, and more. Generate compliant eCTD submissions tailored to each agency's unique standards.

Major Regulatory Authorities

Full support for the world's leading pharmaceutical regulatory agencies

๐Ÿ‡บ๐Ÿ‡ธ

FDA

United States
Food and Drug Administration

World's most influential regulatory agency with rigorous standards for NDA, BLA, and ANDA submissions.

Submission Types:
NDA (New Drug Application)BLA (Biologics License Application)ANDA (Abbreviated NDA)IND (Investigational New Drug)
Review Timeline
Standard Review: 10 months, Priority Review: 6 months
๐Ÿ‡ช๐Ÿ‡บ

EMA

European Union
European Medicines Agency

Centralized procedure for marketing authorization across all EU member states, Iceland, Liechtenstein, and Norway.

Submission Types:
MAA (Marketing Authorization Application)Conditional MAAOrphan Drug MAABiosimilar MAA
Review Timeline
Centralized Procedure: 210 days (Day 120 LoQ, Day 180 final questions)
๐Ÿ‡ฏ๐Ÿ‡ต

PMDA

Japan
Pharmaceuticals and Medical Devices Agency

Japanese regulatory authority requiring bilingual submissions and unique CMC requirements for pharmaceutical approvals.

Submission Types:
J-NDA (New Drug Application)ANDA (Generic)Biological Products ApplicationOrphan Drug Application
Review Timeline
Standard Review: 12 months, Priority Review: 6-9 months
๐Ÿ‡จ๐Ÿ‡ณ

NMPA

China
National Medical Products Administration

Chinese regulatory authority with rapidly evolving requirements and increasing alignment with ICH guidelines.

Submission Types:
NDA (New Drug Application)ANDA (Generic)Imported Drug RegistrationBiological Product Application
Review Timeline
Standard Review: 12-18 months, Priority Review: 6-12 months
๐Ÿ‡จ๐Ÿ‡ฆ

Health Canada

Canada
Health Canada - Therapeutic Products Directorate

Canadian regulatory authority requiring bilingual (English/French) labeling and eCTD submissions aligned with ICH.

Submission Types:
NDS (New Drug Submission)ANDS (Abbreviated NDS)SNDS (Supplemental NDS)Biologic Drug Submission
Review Timeline
Standard Review: 300 days, Priority Review: 180 days
๐Ÿ‡ฆ๐Ÿ‡บ

TGA

Australia
Therapeutic Goods Administration

Australian regulatory authority with streamlined pathways for products already approved by FDA, EMA, or other reference agencies.

Submission Types:
New Chemical Entity RegistrationGeneric Medicine RegistrationBiologicals RegistrationOver-the-Counter Registration
Review Timeline
Standard Review: 255 working days, Priority Review: varies
๐Ÿ‡ฟ๐Ÿ‡ฆ

SAHPRA

South Africa
South African Health Products Regulatory Authority

South African regulatory authority with Climatic Zone IVB requirements and unique local compliance needs.

Submission Types:
New Chemical EntityGeneric RegistrationBiological RegistrationComplementary Medicines
Review Timeline
Standard Review: 24 months, Expedited: 12 months
๐Ÿ‡ฌ๐Ÿ‡ง

MHRA

United Kingdom
Medicines and Healthcare products Regulatory Agency

UK regulatory authority post-Brexit with new pathways independent of EMA while maintaining high scientific standards.

Submission Types:
UK MAAGreat Britain National ProcedureNorthern Ireland AuthorizationReliance Pathway
Review Timeline
Standard Review: 150 days (rolling review available)
EXTENDED COVERAGE

19 Additional Agencies

Beyond major markets, DossiAIr provides regulatory prompts and compliance support for emerging pharmaceutical markets worldwide

๐Ÿ‡ฎ๐Ÿ‡ณ

CDSCO

India
๐Ÿ‡ฒ๐Ÿ‡ฝ

COFEPRIS

Mexico
๐Ÿ‡ง๐Ÿ‡ท

ANVISA

Brazil
๐Ÿ‡ฐ๐Ÿ‡ท

MFDS

South Korea
๐Ÿ‡ธ๐Ÿ‡ฌ

HSA

Singapore
๐Ÿ‡จ๐Ÿ‡ญ

Swissmedic

Switzerland
๐Ÿ‡ธ๐Ÿ‡ฆ

SFDA

Saudi Arabia
๐Ÿ‡ท๐Ÿ‡บ

Roszdravnadzor

Russia
๐Ÿ‡น๐Ÿ‡ท

TITCK

Turkey
๐Ÿ‡ฆ๐Ÿ‡ท

ANMAT

Argentina
๐Ÿ‡ฎ๐Ÿ‡ฉ

BPOM

Indonesia
๐Ÿ‡น๐Ÿ‡ญ

Thailand FDA

Thailand

3,400+ Agency-Specific Prompts

Each agency has dedicated regulatory prompts covering local requirements, language needs, stability zones, and regional compliance standards. Prompts are continuously updated as guidelines change.

Global Coverage

Support for regulatory agencies across all major pharmaceutical markets

๐ŸŒŽ

North America

FDA (USA)
Health Canada
COFEPRIS (Mexico)
๐ŸŒ

Europe

EMA (EU)
MHRA (UK)
Swissmedic
Roszdravnadzor (Russia)
TITCK (Turkey)
๐ŸŒ

Asia-Pacific

PMDA (Japan)
NMPA (China)
TGA (Australia)
MFDS (Korea)
HSA (Singapore)
CDSCO (India)
BPOM (Indonesia)
Thailand FDA
๐ŸŒ

Americas & Africa

ANVISA (Brazil)
ANMAT (Argentina)
SAHPRA (South Africa)
SFDA (Saudi Arabia)
UAE MOH

Agency-Specific Intelligence

Built-in knowledge of unique requirements for each regulatory authority

๐Ÿ“‹

Module 1 Formatting

Agency-specific Module 1 generation with correct forms, cover letters, and administrative documents.

โ€ข FDA: Form 356h, User Fee Cover Sheet, Patent Certifications
โ€ข EMA: Application Form, QRD templates, Product Information
โ€ข PMDA: Application Form, Japanese package insert (ๆทปไป˜ๆ–‡ๆ›ธ)
๐ŸŒ

Language Support

Multi-language document generation and translation for international submissions.

โ€ข PMDA: English-Japanese bilingual support
โ€ข Health Canada: English-French bilingual labeling
โ€ข NMPA: Chinese translation support
๐Ÿ“Š

Data Standards

Compliance with agency-specific data format requirements and standards.

โ€ข FDA: CDISC (SDTM, ADaM) for clinical data
โ€ข EMA: EudraCT, XEVMPD for product registration
โ€ข PMDA: MedDRA Japanese translation (MedDRA/J)
๐Ÿ”

Submission Gateways

Export formats compatible with each agency's electronic submission gateway.

โ€ข FDA: ESG (Electronic Submissions Gateway)
โ€ข EMA: CESP (Centralized Electronic Submission Platform)
โ€ข Health Canada: ECTD Validation Tool
๐Ÿ“

Regulatory Prompts

3,400+ agency-specific regulatory prompts ensure compliance with local guidelines.

โ€ข FDA: 21 CFR Part 314 requirements
โ€ข EMA: EU GMP Annex requirements
โ€ข PMDA: Japanese regulatory guidance
โœ…

Validation Rules

Pre-submission validation against agency-specific technical specifications.

โ€ข FDA: ESG business rules validation
โ€ข EMA: EU Module 1 validation checks
โ€ข ICH: XML backbone validation

Ready for Global Regulatory Success?

See how DossiAIr can generate agency-compliant submissions for FDA, EMA, PMDA, and other global authorities.